Expression and function of ephrin-B1 and its cognate receptor EphB2 in human atherosclerosis: from an aspect of chemotaxis.

Although several cytokines and chemokines have been demonstrated to play pivotal roles in the pathophysiological conditions of atherosclerosis, few findings exist regarding the expression and function of cytokine-modulating molecules such as ephrin-Bs and their cognate receptors, EphBs, in human atherosclerosis. Therefore, in the present study, we screened novel genes modulating atherogenesis by cDNA array and quantitatively determined them by real-time RT (reverse transcription)-PCR in human carotid atherosclerotic plaques. Ephrin-B1 and EphB2, key regulators of embryogenesis, were significantly up-regulated in plaques compared with those in adjacent control tissues [ephrin-B1, 0.638+/-0.106 compared with 0.831+/-0.152, or 130% (P<0.05); EphB2, 1.296+/-0.281 compared with 2.233+/-0.506, or 172% (P<0.05)]. Immunohistological analysis demonstrated that both ephrin-B1 and EphB2 were expressed in macrophages and T-lymphocytes in plaques as well as in monocytes, T-lymphocytes and arterial endothelial cells isolated from healthy adults. Interestingly, the extracellular domains of ephrin-B1 and EphB2, the expression of which were both enhanced in stimulated THP-1 cells, significantly inhibited spontaneous (22.5 and 27.6% respectively; P<0.01) and MCP-1 (monocyte chemoattractant protein-1)-dependent (29.7 and 22.6% respectively; P<0.01) migration of monocytes. In conclusion, these results demonstrate that ephrin-B1 and EphB2 are overexpressed in atherosclerotic tissue and might locally regulate cell migration, possibly through modulating cytokine-related chemotaxic activity; however, the functional role of these molecules in atherogenesis should be investigated further.

[1]  P. Oettgen,et al.  Controversies in Cardiovascular Medicine: Ready for the Next Step , 2006 .

[2]  R. Djukanović,et al.  Inflammatory cells in the airways in COPD , 2006, Thorax.

[3]  K. Iihara,et al.  Altered expression balance of matrix metalloproteinases and their inhibitors in human carotid plaque disruption: results of quantitative tissue analysis using real-time RT-PCR method. , 2006, Atherosclerosis.

[4]  K. Iihara,et al.  Sustained upregulation of inflammatory chemokine and its receptor in aneurysmal and occlusive atherosclerotic disease: results form tissue analysis with cDNA macroarray and real-time reverse transcriptional polymerase chain reaction methods. , 2005, Circulation journal : official journal of the Japanese Circulation Society.

[5]  R. Busse,et al.  Role of macrophage tissue infiltration in metabolic diseases , 2005, Current opinion in clinical nutrition and metabolic care.

[6]  Hongyu Luo,et al.  Recent advances on T-cell regulation by receptor tyrosine kinases , 2005, Current opinion in hematology.

[7]  C. Teunissen,et al.  Macrophages and neurodegeneration , 2005, Brain Research Reviews.

[8]  R. Pope,et al.  The role of macrophages in rheumatoid arthritis. , 2005, Current pharmaceutical design.

[9]  Yulian Wu,et al.  EphrinB1 Is Essential in T-cell-T-cell Co-operation during T-cell Activation* , 2004, Journal of Biological Chemistry.

[10]  M. Yamagishi,et al.  Application of real-time RT-PCR to quantifying gene expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human abdominal aortic aneurysm. , 2004, Atherosclerosis.

[11]  M. Aurrand-Lions,et al.  Adhesion mechanisms regulating the migration of monocytes , 2004, Nature Reviews Immunology.

[12]  A. Shuaib,et al.  Current and future concepts in stroke prevention , 2004, Canadian Medical Association Journal.

[13]  B. Osterud,et al.  Role of monocytes in atherogenesis. , 2003, Physiological reviews.

[14]  R. Salcedo,et al.  Tannic Acid Is an Inhibitor of CXCL12 (SDF-1α)/CXCR4 with Antiangiogenic Activity , 2003 .

[15]  K. Murai,et al.  `Eph'ective signaling: forward, reverse and crosstalk , 2003, Journal of Cell Science.

[16]  R. Klein,et al.  Multiple roles of ephrins in morphogenesis, neuronal networking, and brain function. , 2003, Genes & development.

[17]  O. Grip,et al.  Macrophages in inflammatory bowel disease. , 2003, Current drug targets. Inflammation and allergy.

[18]  P. Libby.  Inflammation in atherosclerosis , 2002, Nature.

[19]  A. Freywald,et al.  Ephrin stimulation modulates T cell chemotaxis , 2002, European journal of immunology.

[20]  David C. Han,et al.  Differential gene expression in human abdominal aorta: aneurysmal versus occlusive disease. , 2002, Journal of vascular surgery.

[21]  D. Greaves,et al.  Atherosclerosis: role of chemokines and macrophages , 2001, Expert Reviews in Molecular Medicine.

[22]  R. Klein,et al.  Ephrin-B Reverse Signaling Is Mediated by a Novel PDZ-RGS Protein and Selectively Inhibits G Protein–Coupled Chemoattraction , 2001, Cell.

[23]  Y. Murakami,et al.  Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Y. Furukawa,et al.  Up-regulation of VLA-5 expression during monocytic differentiation and its role in negative control of the survival of peripheral blood monocytes. , 1996, Journal of immunology.

[25]  D. Mason,et al.  Distribution of the CD68 macrophage/myeloid associated antigen. , 1990, International immunology.

[26]  S Gordon,et al.  Macrophage receptors and immune recognition. , 2005, Annual review of immunology.

[27]  D. Rateri,et al.  Cytokine regulation of macrophage functions in atherogenesis , 2005 .